Ganirelix

China [CN]

Ganirelix is a medication used to prevent premature ovulation in women undergoing controlled ovarian stimulation for assisted reproductive technologies, such as in vitro fertilization (IVF). It works by blocking the action of gonadotropin-releasing hormone (GnRH), thereby suppressing the release of luteinizing hormone (LH) from the pituitary gland. Given as a once-daily subcutaneous injection during the treatment cycle, common side effects include mild injection site reactions, headache, and nausea.